Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea: a randomized pilot study.

Wang GJ, Gao XY, Wu Y, He HQ, Yu Y, Qin HH, Shen WT.

J Dermatolog Treat. 2019 Aug 20:1-4. doi: 10.1080/09546634.2019.1610549. [Epub ahead of print]

PMID:
31017492
2.

Isoalantolactone suppresses LPS-induced inflammation by inhibiting TRAF6 ubiquitination and alleviates acute lung injury.

Ding YH, Song YD, Wu YX, He HQ, Yu TH, Hu YD, Zhang DP, Jiang HC, Yu KK, Li XZ, Sun L, Qian F.

Acta Pharmacol Sin. 2019 Jan;40(1):64-74. doi: 10.1038/s41401-018-0061-3. Epub 2018 Jul 16.

PMID:
30013035
3.

Protostemonine effectively attenuates lipopolysaccharide-induced acute lung injury in mice.

Wu YX, He HQ, Nie YJ, Ding YH, Sun L, Qian F.

Acta Pharmacol Sin. 2018 Jan;39(1):85-96. doi: 10.1038/aps.2017.131. Epub 2017 Oct 19.

4.

The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.

He HQ, Ye RD.

Molecules. 2017 Mar 13;22(3). pii: E455. doi: 10.3390/molecules22030455. Review.

5.

LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway.

He HQ, Wu YX, Nie YJ, Wang J, Ge M, Qian F.

Acta Pharmacol Sin. 2017 Mar;38(3):342-350. doi: 10.1038/aps.2016.141. Epub 2017 Jan 23.

6.

Shikonin Derivative DMAKO-05 Inhibits Akt Signal Activation and Melanoma Proliferation.

Yang YY, He HQ, Cui JH, Nie YJ, Wu YX, Wang R, Wang G, Zheng JN, Ye RD, Wu Q, Li SS, Qian F.

Chem Biol Drug Des. 2016 Jun;87(6):895-904. doi: 10.1111/cbdd.12722. Epub 2016 Feb 18.

PMID:
26804061
7.

Chemerin C9 peptide induces receptor internalization through a clathrin-independent pathway.

Zhou JX, Liao D, Zhang S, Cheng N, He HQ, Ye RD.

Acta Pharmacol Sin. 2014 May;35(5):653-63. doi: 10.1038/aps.2013.198. Epub 2014 Mar 24.

8.

Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands.

He HQ, Troksa EL, Caltabiano G, Pardo L, Ye RD.

J Biol Chem. 2014 Jan 24;289(4):2295-306. doi: 10.1074/jbc.M113.509216. Epub 2013 Nov 27. Erratum in: J Biol Chem. 2014 Feb 21;289(8):4814.

9.

Functional characterization of three mouse formyl peptide receptors.

He HQ, Liao D, Wang ZG, Wang ZL, Zhou HC, Wang MW, Ye RD.

Mol Pharmacol. 2013 Feb;83(2):389-98. doi: 10.1124/mol.112.081315. Epub 2012 Nov 15.

10.

Pharmacological kinetics of BmK AS, a sodium channel site 4-specific modulator on Nav1.3.

Liu ZR, Tao J, Dong BQ, Ding G, Cheng ZJ, He HQ, Ji YH.

Neurosci Bull. 2012 Jun;28(3):209-21. doi: 10.1007/s12264-012-1234-6.

11.

Deglycosylation altered the gating properties of rNav1.3: glycosylation/deglycosylation homeostasis probably complicates the functional regulation of voltage-gated sodium channel.

Xu Q, Cheng HW, He HQ, Liu ZR, He M, Yang HT, Zhou ZL, Ji YH.

Neurosci Bull. 2008 Oct;24(5):283-7. doi: 10.1007/s12264-008-0524-5.

12.

Inhibition of martentoxin on neuronal BK channel subtype (alpha+beta4): implications for a novel interaction model.

Shi J, He HQ, Zhao R, Duan YH, Chen J, Chen Y, Yang J, Zhang JW, Shu XQ, Zheng P, Ji YH.

Biophys J. 2008 May 1;94(9):3706-13. doi: 10.1529/biophysj.107.122150. Epub 2008 Jan 16.

13.

Comparative pharmacology and cloning of two novel arachnid sodium channels: Exploring the adaptive insensitivity of scorpion to its toxins.

Zuo XP, He HQ, He M, Liu ZR, Xu Q, Ye JG, Ji YH.

FEBS Lett. 2006 Aug 7;580(18):4508-14. Epub 2006 Jul 17.

Supplemental Content

Loading ...
Support Center